Filter
380
Text search:
pathogenesis
Featured
36
65
Language
Document type
184
83
66
22
9
7
6
1
1
1
Countries
24
16
11
11
9
7
6
6
6
5
5
5
5
5
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
105
69
24
15
7
7
4
Toolboxes
55
45
44
26
20
16
9
9
9
8
4
4
4
4
4
3
3
2
2
2
2
1
1
1
THELANCETID-D-16-00800 S1473-3099(16)30318-8
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
Diagnosis and Management of Systemic Lupus Erythematosus
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution
...
Policy framework.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
